An earlier FTC report published in July 2024 argued that the six largest PBMs were effectively running a monopoly that gave them enormous power over the price of medicines and allowed them to ...

A long-awaited report from the US Federal Trade Commission (FTC) on pharmacy benefit managers (PBMs) is out – and will make uncomfortable reading for the pharma supply chain middlemen.

The three largest pharmacy benefit managers are looking to take their legal back-and-forth with the Federal Trade Commission ...

Al Roberts and Travis Hale, the owners of Remington Drug Company in Remington, Va., hosted Andrew Ferguson, chair of the ...

Prescription medication is counted before being placed into a bottle for customer pickup on Friday, Nov. 10, 2023. (Geoff ...

The Federal Trade Commission filed a lawsuit against PBMs last September ... later releasing two reports, most recently last month, slamming them for practices the agency deemed anticompetitive ...

FTC court order requires CVS Health to share more documents about Caremark Rx PBM practices as part of ongoing investigation ...

Pharmacy Benefit Managers (PBMs) have evolved from relatively obscure cost-saving entities into powerful industry players ...

"So when you look at all the data, not cherry-picked data points like those specifically referenced in the FTC interim reports, the conclusion is clear, PBMs deliver savings to their clients ...

In Gov. JB Pritzker’s Illinois budget address on Feb. 19, he lamented the decline of small-town independent pharmacies like ...

When it comes to high drug costs for consumers, pharmacy benefit managers are not the villains, the new CVS chief executive said Wednesday. When it comes to high drug costs for consumers, pharmacy ...